Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia

Brain and Behavior

Volumn 2, Issue 2, 2012, Pages 155-177

  Wilkerson, Jenny L ^a   Gentry, Katherine R ^a   Dengler, Ellen C ^a   Wallace, James A ^a   Kerwin, Audra A ^a   Kuhn, Megan N ^a   Zvonok, Alexander M ^b   Thakur, Ganesh A ^b   Makriyannis, Alexandros ^b   Milligan, Erin D ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

CCI; DRG; MAGL; Pain; Paraffin immunohistochemistry

Indexed keywords

3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 4',6 DIAMIDINO 2 PHENYLINDOLE; ACYLGLYCEROL LIPASE; FATTY ACID AMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME DEGRADATION; FLUORESCENCE SPECTROSCOPY; GLIA CELL; IMMUNOFLUORESCENT SPECTRAL ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NEUROMODULATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPECTROSCOPY; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

EID: 84878013013     PISSN: 21623279     EISSN: 21579032     Source Type: Journal    
DOI: 10.1002/brb3.44     Document Type: Article

References (116)

1. Achstatter, T., R. Moll, A. Anderson, C. Kuhn, S. Pitz, K. Schwechheimer, andW.W. Franke. 1986. Expression of glial filament protein (GFP) in nerve sheaths and non-neural cells re-examined using monoclonal antibodies, with special emphasis on the co-expression of GFP and cytokeratins in epithelial cells of human salivary gland and pleomorphic adenomas. Differentiation 31:206-227.
2. Andres, C., S.Meyer, O. A.Dina, J. D. Levine, and T. Hucho. 2010. Quantitative automated microscopy (QuAM) elucidates growth factor specific signalling in pain sensitization. Mol. Pain 6:98.
3. Basavarajappa, B. S. 2007. Critical enzymes involved in endocannabinoid metabolism. Protein Pept. Lett. 14:237-246.
4. Bellucci, A., A. J. Westwood, E. Ingram, F. Casamenti, M. Goedert, and M. G. Spillantini. 2004. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am. J. Pathol. 165:1643-1652.
5. Beltramo, M., N. Bernardini, R. Bertorelli, M. Campanella, E. Nicolussi, S. Fredduzzi, and A. Reggiani. 2006. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci. 23:1530-1538.
6. Bennett, G. J., and K. Y. Xie. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
7. Bessiere, B., E. Laboureyras, J. Chateauraynaud, J. P. Laulin, and G. Simonnet. 2009. A single nitrous oxide (N2O) exposure leads to persistent alleviation of neuropathic pain in rats. J. Pain 11:13-23.
8. Binshtok, A. M., H.Wang, K. Zimmermann, F. Amaya, D. Vardeh, L. Shi, G. J. Brenner, R. R. Ji, B. P. Bean, C. J.Woolf, et al. 2008. Nociceptors are interleukin-1beta sensors. J. Neurosci. 28:14062-14073.
9. Booker, L., S.G. Kinsey, R. A. Abdullah, J. L. Blackman, J. Z. Long, C. Ezzili, D. L. Boger, B. F. Cravatt, and A. H. Lichtman. 2011. The FAAH inhibitor PF-3845 acts in the nervous system to reverse lipopolysaccharide-induced tactile allodynia in mice. Br. J. Pharmacol. (In press).
10. Boyle, D. L., T. L. Jones, D. Hammaker, C. I. Svensson, S. Rosengren, S. Albani, L. Sorkin, and G. S. Firestein. 2006. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med. 3:e338.
11. Cabral, G. A., and F. Marciano-Cabral. 2005. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J. Leukoc. Biol. 78:1192-1197.
12. Cabral, G. A., E. S. Raborn, L. Griffin, J.Dennis, and F. Marciano-Cabral. 2008. CB2 receptors in the brain: role in central immune function. Br. J. Pharmacol. 153:240-251.
13. Chaplan, S. R., F.W. Bach, J. W. Pogrel, J.M. Chung, and T. L. Yaksh. 1994. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Meth. 53:55-63.
14. Choi, J., D. R. Nordli Jr., T. D. Alden, A. DiPatri Jr., L. Laux, K. Kelley, J. Rosenow, S.U. Schuele, V. Rajaram, and S. Koh. 2009. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J. Neuroinflammation 6:38.
15. Constantinou, P., R. S. Dacosta, and B. C.Wilson. 2009. Extending immunofluorescence detection limits in whole paraffin-embedded formalin fixed tissues using hyperspectral confocal fluorescence imaging. J. Microsc. 234:137-146.
16. Correa, F., L. Mestre, F. Docagne, and C. Guaza. 2005. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br. J. Pharmacol. 145:441-448.
17. De Leo, J. A., V. L. Tawfik, and M. L. LaCroix-Fralish. 2006. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 122:17-21.
18. DeLeo, J. A., L. S. Sorkin, and L. R.Watkins, eds. 2007. Immune and glial regulation of pain. IASP Press, Seattle.
19. Dinh, T. P., T. F. Freund, and D. Piomelli. 2002. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem. Phys. Lipids 121:149-158.
20. Dubovy, P., I. Klusakova, I. Svizenska, and V. Brazda. 2010. Satellite glial cells express IL-6 and corresponding signal-transducing receptors in the dorsal root ganglia of rat neuropathic pain model. Neuron Glia Biol. 6:73-83.
21. Ehrhart J., D.Obregon, T.Mori, H. Hou, N. Sun, Y. Bai, T. Klein, F. Fernandez, J. Tan, and R. D. Shytle. 2005. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation 2:1-29.
22. Fukudome, Y., T. Tabata, T. Miyoshi, S. Haruki, K. Araishi, S. Sawada, and M. Kano. 2003. Insulin-like growth factor-I as a promoting factor for cerebellar Purkinje cell development. Eur. J. Neurosci. 17:2006-2016.
23. Gulyas, A. I., B. F. Cravatt, M. H. Bracey, T. P. Dinh, D. Piomelli, F. Boscia, and T. F. Freund. 2004. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur. J. Neurosci. 20:441-458.
24. Hanani, M. 2005. Satellite glial cells in sensory ganglia: from form to function. Brain Res. Brain Res. Rev. 48:457-476.
25. Hashizume, H., J. A. DeLeo, R.W. Colburn, and J. N. Weinstein. 2000. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25:1206-1217.
26. Holguin, A., K. A. O'Connor, J. Biedenkapp, J. Campisi, J. Wieseler-Frank, E. D. Milligan, M. K. Hansen, L. Spataro, E. Maksimova, C. Bracmann, et al. 2004. HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain 110:517-530.
27. Hor, S., H. Pirzer, L. Dumoutier, F. Bauer, S.Wittmann, H. Sticht, J. C. Renauld, R. deWaal Malefyt, and H. Fickenscher. 2004. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J. Biol. Chem. 279:33343-33351.
28. Hsieh, G. C., M. Pai, P. Chandran, B. A. Hooker, C. Z. Zhu, A. K. Salyers, E. J. Wensink, C. Zhan, W. A. Carroll, M. J. Dart, et al. 2011. Central and peripheral sites of action for CB receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br. J. Pharmacol. 162:428-440.
29. Ibrahim, A. S., M. M. El-Shishtawy, A. Pena Jr., and G. I. Liou. 2010. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol. Vis. 16:2033-2042.
30. Ibrahim, M. M., H. Deng, A. Zvonok, D. A. Cockayne, J. Kwan, H. P. Mata, T.W. Vanderah, J. Lai, F. Porreca, A. Makriyannis, et al. 2003. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. U.S.A. 100:10529-10533.
31. Ibrahim, M. M., M. L. Rude, N. J. Stagg, H. P. Mata, J. Lai, T.W. Vanderah, F. Porreca, N. E. Buckley, A. Makriyannis, and T. P. Malan Jr. 2006. CB2 cannabinoid receptor mediation of antinociception. Pain 122:36-42.
32. Imai, Y., I. Ibata, D. Ito, K. Ohsawa, and S. Kohsaka. 1996. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224:855-862.
33. Jancalek, R., P. Dubovy, I. Svizenska, and I. Klusakova. 2010. Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J. Neuroinflammation 7:11.
34. Jancalek, R., I. Svizenska, I. Klusakova, and P. Dubovy. 2011. Bilateral changes of IL-10 protein in lumbar and cervical dorsal root ganglia following proximal and distal chronic constriction injury of peripheral nerve. Neurosci. Lett. 501:86-91.
35. Ji, R. R., and M. R. Suter. 2007. p38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain 3:33.
36. Ji, R. R., R.W. Gereaut, M. Malcangio, and G. R. Strichartz. 2009. MAP kinase and pain. Brain Res. Rev. 60:135-148.
37. Jin, S. X., Z. Y. Zhuang, C. J.Woolf, and R. R. Ji. 2003. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23:4017-4022.
38. Kawasaki, Y., Z. Z. Xu, X.Wang, J. Y. Park, Z. Y. Zhuang, P. H. Tan, Y. J. Gao, K. Roy, G. Corfas, E. H. Lo, et al. 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 14:331-336.
39. Khanolkar, A. D., D. Lu, M. Ibrahim, R. I. Duclos Jr., G. A. Thakur, T. P. Malan Jr., F. Porreca, V. Veerappan, X. Tian, C. George, et al. 2007. Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity. J. Med. Chem. 50:6493-6500.
40. Kinsey, S. G., J. Z. Long, S. T. O'Neal, R. A. Abdullah, J. L. Poklis, D. L. Boger, B. F. Cravatt, and A. H. Lichtman. 2009. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J. Pharmacol. Exp. Ther. 330:902-910.
41. Kinsey, S. G., J. Z. Long, B. F. Cravatt, and A. H. Lichtman. 2010. Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms. J. Pain 11:1420-1428.
42. Kraft, A. D., L. S. Kaltenbach, D. C. Lo, and G. J. Harry. 2011. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Neurobiol. Aging 3:621.e17-621.e33.
43. Ledeboer, A., E. M. Sloane, E. D. Milligan, S. J. Langer, S. F. Maier, K.W. Johnson, L. A. Leinwand, R. A. Chavez, and L. R. Watkins. 2006. Paclitaxel-induced mechanical allodynia in rats is inhibited by spinal delivery of plasmid DNA encoding interleukin-10. Pp. 187-194 inH. Flor, E. Kalso, and J. O. Dostrovsky, eds. Proceedings of the 11thWorld Congress on Pain. International Association for the Study of Pain, Sydney, Australia.
44. Leiphart, J.W., C. V. Dills, and R. M. Levy. 2003. Decreased spinal alpha2a- and alpha2c-adrenergic receptor subtype mRNA in a rat model of neuropathic pain. Neurosci. Lett. 349:5-8.
45. Lever, I. J., M. Robinson, M. Cibelli, C. Paule, P. Santha, L. Yee, S. P. Hunt, B. F. Cravatt, M. R. Elphick, I. Nagy, et al. 2009. Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J. Neurosci. 29:3766-3780.
46. Liu, Y. L., L. J. Zhou, N.W.Hu, J. T. Xu, C. Y.Wu, T. Zhang, Y. Y. Li, and X. G. Liu. 2007. Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology 52:708-715.
47. Long, J. Z., D. K.Nomura, R. E. Vann, M.Walentiny, L. Booker, X. Jin, J. J. Burston, L. J. Sim-Selley, A. H. Lichtman, J. L. Wiley, et al. 2009. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc. Natl. Acad. Sci. U.S.A. 106:20270-20275.
48. Loram, L. C., J. A. Harrison, E.M. Sloane, M. R. Hutchinson, P. Sholar, F. R. Taylor, D. Berkelhammer, B. D. Coats, S. Poole, E. D. Milligan, et al. 2009. Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. J. Neurosci. 44:14015-14025.
49. Mahad, D. J., I. Ziabreva, G. Campbell, F. Laulund, J. L. Murphy, A. K. Reeve, L. Greaves, K. J. Smith, and D. M. Turnbull. 2009. Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J. Neurosci. Methods 184: 310-319.
50. Mansfield, J. R., C. Hoyt, and R. M. Levenson. 2008. Visualization of microscopy-based spectral imaging data from multi-label tissue sections. Curr. Protoc. Mol. Biol., Chapter 14, Unit 14-19.
51. Marquez, L., J. Suarez, M. Iglesias, F. J. Bermudez-Silva, F. Rodriguez de Fonseca, and M. Andreu. 2009. Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue. PLoS One 4:e6893.
52. Martin, A., R. Boisgard, B. Theze, N. Van Camp, B. Kuhnast, A. Damont, M. Kassiou, F. Dolle, and B. Tavitian. 2010. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 30:230-241.
53. Martin, W. J., C. M. Loo, and A. I. Basbaum. 1999. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain 82:199-205.
54. Milligan, E. D., and L. R.Watkins. 2009. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10:23-36.
55. Milligan, E. D., K. K. Mehmert, J. L. Hinde, L. O. J. Harvey, D. Martin, K. J. Tracey, S. F. Maier, and L. R.Watkins. 2000. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the Human Immunodeficiency Virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861:105-116.
56. Milligan, E. D., S. J. Langer, E. M. Sloane, L. He, J. Wieseler-Frank, K. A. O'Connor, D.Martin, J. R. Forsayeth, S. F. Maier, K. Johnson, et al. 2005a. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, Interleukin-10. Eur. J. Neurosci. 21:2136-2148.
57. Milligan, E. D., E.M. Sloane, S. J. Langer, P. E. Cruz, M. Chacur, L. Spataro, Wieseler-J. Frank, S. E. Hammack, S. F. Maier, T. R. Flotte, et al. 2005b. Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol. Pain 1:9-22.
58. Milligan, E. D., E.M. Sloane, S. J. Langer, T. R.Hughes, B. M. Jekich, M. G. Frank, J. H. Mahoney, L. H. Levkoff, S. F. Maier, P. E. Cruz, et al. 2006. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126:294-308.
59. Milligan, E. D., R. G. Soderquist, S. M. Malone, J. H. Mahoney, T. S. Hughes, S. J. Langer, E. M. Sloane, S. F. Maier, L. A. Leinwand, L. R.Watkins, et al. 2007. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol. 2:1-16.
60. Molina-Holgado, F., E. Pinteaux, J. D. Moore, Molina-E. Holgado, C. Guaza, R. M. Gibson, and N. J. Rothwell. 2003. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J. Neurosci. 23:6470-6474.
61. Muccioli, G. G., C. Xu, E. Odah, E. Cudaback, J. A. Cisneros, D. M. Lambert, M. L. Lopez Rodriguez, S. Bajjalieh, and N. Stella. 2007. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J. Neurosci. 27:2883-2889.
62. Nackley, A.G., A. M. Zvonok, A.Makriyannis, and A. G. Hohmann. 2004. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J. Neurophysiol. 92:3562-3574.
63. Nunez, E., C. Benito, R. M. Tolon, C. J. Hillard, W. S. Griffin, and J. Romero. 2008. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome. Neuroscience 151:104-110.
64. Obata, H., S. Sakurazawa, M. Kimura, and S. Saito. 2010. Activation of astrocytes in the spinal cord contributes to the development of bilateral allodynia after peripheral nerve injury in rats. Brain Res. 1363:72-80.
65. Ohsawa, K., Y. Imai, H. Kanazawa, Y. Sasaki, and S. Kohsaka. 2000. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell Sci. 113(Pt 17):3073-3084.
66. Paulson, P. E., T. J. Morrow, and K. L. Casey. 2000. Bilateral behavioral and regional cerebral blood flow changes during painful peripheral mononeuropathy in the rat. Pain 84:233-245.
67. Paulson, P. E., K. L. Casey, and T. J. Morrow. 2002. Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral monotherapy in the rat. Pain 95:31-40.
68. Pekny, M., and M. Pekna. 2004. Astrocyte intermediate filaments in CNS pathologies and regeneration. J. Pathol. 204:428-437.
69. Plunkett, J. A., C.-G. Yu, J.m. Easton, J. R. Bethea, and R. P. Yezierski. 2001. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 168:144-154.
70. Racz, I., X. Nadal, J. Alferink, J. E. Banos, J. Rehnelt, M. Martin, B. Pintado, A. Gutierrez-Adan, E. Sanguino, N. Bellora, et al. 2008a. Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J. Neurosci. 28:12136-12145.
71. Racz, I., X. Nadal, J. Alferink, J. E. Banos, J. Rehnelt, M. Martin, B. Pintado, A. Gutierrez-Adan, E. Sanguino, J. Manzanares, et al. 2008b. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J. Neurosci. 28:12125-12135.
72. Rahn, E. J., A. Makriyannis, and A. G. Hohmann. 2007. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br. J. Pharmacol. 152:765-777.
73. Rahn, E. J., A. M. Zvonok, G. A. Thakur, A. D. Khanolkar, A. Makriyannis, and A. G. Hohmann. 2008. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. J. Pharmacol. Exp. Ther. 327:584-591.
74. Rahn, E. J., A. M. Zvonok, A. Makriyannis, and A. G. Hohmann. 2010. Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation. AAPS J. 12:147-157.
75. Reed, J. R., R. P. Leon, M. K. Hall, and K. L. Schwertfeger. 2009. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res. 11:R21.
76. Ro, L. S., H. Y. Li, K. F. Huang, and S. T. Chen. 2004. Territorial and extra-territorial distribution of Fos protein in the lumbar spinal dorsal horn neurons in rats with chronic constriction nerve injuries. Brain Res. 1004:177-187.
77. Romero-Sandoval, A., and J. C. Eisenach. 2007. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 106:787-794.
78. Romero-Sandoval, A., N. Nutile-McMenemy, and J. A. DeLeo. 2008a. Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 108:722-734.
79. Romero-Sandoval, E. A., R. J. Horvath, and J. A. Deleo. 2008b. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr. Opin. Investig. Drugs 9:726-734.
80. Romero-Sandoval, E. A., R. Horvath, R. P. Landry, and J. A. DeLeo. 2009. Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation. Mol. Pain 5:25.
81. Sagar, D. R., A. G. Gaw, B. N. Okine, S. G.Woodhams, A.Wong, D. A. Kendall, and V. Chapman. 2009. Dynamic regulation of the endocannabinoid system: implications for analgesia. Mol. Pain 5:59.
82. Schafers, M., C. I. Svensson, C. Sommer, and L. S. Sorkin. 2003. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23:2517-2521.
83. Scholz, J., and C. J.Woolf. 2007. The neuropathic pain triad: neurons, immune cells, and glia. Nat. Neurosci. 10:1361-1368.
84. Schreiber, K. L., A. J. Beitz, and G. L.Wilcox. 2008. Activation of spinal microglia in a murine model of peripheral inflammatory induced, long-lasting contralateral allodynia. Neurosci. Lett. 440:63-67.
85. Shi, X. Q., T. K. Y. Lim, S. Lee, Y. Q. Zhao, and J. Zhang. 2011. Statins alleviate experimental nerve injury-induced neuropathic pain. Pain 152:1033-1043.
86. Siniscalco, D., C. Giordano, U. Galderisi, L. Luongo, V. de Novellis, F. Rossi, and S. Maione. 2011. Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front. Integr. Neurosci. 5:1-10.
87. Sloane, E. M., S. J. Langer, B. M. Jekich, J. H. Mahoney, T. S. Hughes, W. Seibert, K. Johnson, R. A. Chavez, L. R.Watkins, L. A. Leinwand, et al. 2009a. Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain. Gene Ther. 16:1210-1222.
88. Sloane, E. M., R.G. Soderquist, S. F. Maier, M. J. Mahoney, L. R. Watkins, and E. D. Milligan. 2009b. Long-term control of neuropathic pain in a non-viral gene therapy paradigm. Gene Ther. 16:470-475.
89. Soderquist, R. G., E.D.Milligan, J. A. Harrison, R. Chavez, K. Johnson, L. R.Watkins, andM. J.Mahoney. 2010a. PEGylation of interleukin-10 for the mitigation of enhanced pain states. J. Biomed. Mater. Res. A 3:1169-1179.
90. Soderquist, R. G., E. M. Sloane, L. C. Loram, J. A. Harrison, E. C. Dengler, S. M. Johnson, L. D. Amer, C. S. Young, M. T. Lewis, S. Poole, et al. 2010b. Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration. Pharm. Res. 27:841-854.
91. Sorkin, L., C. I. Svensson, T. L. Jones-Cordero, M. P. Hefferan, andW. M. Campana. 2009. Spinal p38 mitogen-activated protein kinase mediates allodynia induced by first-degree burn in the rat. J. Neurosci. Res. 87:948-955.
92. Spataro, L. E., E. M. Sloane, E. D. Milligan, J.Wieseler-Frank, D. Schoeniger, B. M. Jekich, R. M. Barrientos, S. F. Maier, and L. R.Watkins. 2004. Spinal gap junctions: potential involvement in pain facilitation. J. Pain 5:392-405.
93. Starowicz, K. M., L. Cristino, I. Matias, R. Capasso, A. Racioppi, A. A. Izzo, and V. Di Marzo. 2008. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 16:553-565.
94. Stella, N. 2009. Endocannabinoid signaling in microglial cells. Neuropharmacology 56(Suppl 1):244-253.
95. Suter, M. R., T. Berta, Y. J. Gao, I. Decosterd, and R. R. Ji. 2009. Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury. Mol. Pain 5:53.
96. Svensson, C. I., M. Marsala, A. Westerlund, N. A. Calcutt, W. M. Campana, J. D. Freshwater, R. Catalano, Y. Feng, A. A. Protter, B. Scott, et al. 2003. Activation of p38 MAP Kinase in spinal microglia is a critical link in inflammation induced spinal pain processing. J. Neurochem. 6:1534-1544.
97. Svensson, C. I., B. Fitzsimmons, S. Azizi, H. C. Powell, X. Y.Hua, and T. L. Yaksh. 2005a. Spinal p38beta isoform mediates tissue injury-induced hyperalgesia and spinal sensitization. J. Neurochem. 92:1508-1520.
98. Svensson, C. I., M. Schafers, T. L. Jones, H. Powell, and L. S. Sorkin. 2005b. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci. Lett. 379:209-213.
99. Takeda, M., M. Takahashi, and S.Matsumoto. 2008. Contribution of activated interleukin receptors in trigeminal ganglion neurons to hyperalgesia via satellite glial interleukin-1beta paracrine mechanism. Brain Behav. Immun. 22:1016-1023.
100. Takeda, M., M. Takahashi, and S.Matsumoto. 2009. Contribution of the activation of satellite glia in sensory ganglia to pathological pain. Neurosci. Biobehav. Rev. 33:784-792.
101. Thakur, G. A., R. Tichkule, S. Bajaj, and A. Makriyannis. 2009. Latest advances in cannabinoid receptor agonists. Expert Opin. Ther. Pat. 19:1647-1673.
102. Thompson-Snipes, L., V. Dhar, M.W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173:507-510.
103. Toth, C. C., N. M. Jedrzejewski, C. L. Ellis, andW. H. Frey 2nd. 2010. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. Mol. Pain 6:16.
104. Treutwein, B., and H. Strasburger. 1999. Fitting the psychometric function. Percept. Psychophys. 61:87-106.
105. Tsuda, M., Y. Kohro, T. Yano, T. Tsujikawa, J. Kitano, H. Tozaki-Saitoh, S. Koyanagi, S. Ohdo, R. R. Ji, M. Salter, et al. 2011. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 134:1127-1139.
106. Wallace, J. A., A. A. Romero, A.M.Gabaldon, V. A. Roe, S. L. Saavedra, and J. Lobner. 1996. Tyrosine hydroxylase-containing neurons in the spinal cord of the chicken. I. Development and analysis of catecholamine synthesis capabilities. Cell. Mol. Neurobiol. 16:625-648.
107. Walter, L., A. Franklin, A.Witting, C.Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella. 2003. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23:1398-1405.
108. Watkins, L. R., J.Wieseler-Frank, M. R. Hutchinson, A. Ledeboer, L. Spataro, E. D. Milligan, E. M. Sloane, and S. F. Maier. 2007. Neuroimmune interactions and pain: the role of immune and glial cells. Pp. 393-411 in Ader, R., ed. Psychoneuroimmunology. Elsevier, Burlington, MA.
109. Wu, P., Y. I. Tarasenko, Y. Gu, L. Y. Huang, R. E. Coggeshall, and Y. Yu. 2002. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat. Neurosci. 5:1271-1278.
110. Xu, J. T., W. J. Xin, X. H. Wei, C. Y.Wu, Y. X. Ge, Y. L. Liu, Y. Zang, T. Zhang, Y. Y. Li, and X. G. Liu. 2007. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp. Neurol. 204:355-365.
111. 2 receptor? Br. J. Pharmacol. 149:145-154.
112. 2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethylcyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. J. Pharmacol. Exp. Ther. 328:141-151.
113. Yasuo, S., M. Koch, H. Schmidt, S. Ziebell, J. Bojunga, G. Geisslinger, and H.W. Korf.2010. An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes. Cell Tissue Res. 340:127-136.
114. 2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci. 17:2750-2754.
115. Zhuang, Z. Y., P. Gerner, C. J.Woolf, and R. R. Ji. 2005. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114: 149-159.
116. Zhuang, Z.-Y., Y. Kawasaki, P.-H. Tan, Y.-R. Wen, J.Huang, and R.-R. Ji. 2007. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav. Immun. 21:642-651.